NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart drug aims to give patients more energy and less shortness of breath
Symptom relief Recruiting nowThis study tests an experimental pill called ninerafaxstat in 165 adults with a type of thickened heart muscle that causes chest pain, shortness of breath, and fatigue. Participants will receive either the drug or a placebo for several months, while continuing their usual care. T…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Heart drug trial aims to help patients breathe easier
Symptom relief Recruiting nowThis study tests a drug called sotagliflozin in 500 adults with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens, making it harder to pump blood. The goal is to see if the drug improves symptoms like shortness of breath and fatigue, and helps people …
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC